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1. Introduction
The alkaloids are a family of compounds widely found in nature. Therefore, they They are
nitrogenous secondary metabolites heterocyclic derivatives of amino acids or by the transa‐
mination process, which confers basic character [1].
The term alkaloid, linguistically derived from the Arabic al-quali (ash plants), is used to
designate pharmacologically active nitrogen compounds found predominantly in Angio‐
sperms [2]. Their distribution is not uniform in that division. It is estimated that approximately
40% of all plant families have at least one plant species that contains alkaloids. They are easily
found in Fabaceaes and Solanaceaes but are rare in Gymnosperms and Pteridophytes such as
ferns and monocots [3]. Although most occur in plants, alkaloids have also been isolated from
algae, insects, marine and land animals, microorganisms, and fungi [4].
Since the dawn of civilization, there are reports of the use of plant extracts containing alkaloids
for various purposes. The death of Socrates in 399 BC, for example, was attributed to the
consumption of the extract of Conium maculatum containing the alkaloid coniine. There are also
reports that during the last century BC, Cleopatra employed extracts of Hyoscyamus muticus
containing the alkaloid atropine to dilate the pupils to look more attractive. It is known that
medieval European women employed extract from Atropa belladonna with the same goal.
Moreover, 25% of contemporary medicines are plant-derived. For example, morphine is
extracted from the poppy. It is a narcotic drug used as analgesic and marketed since 1827 by
Merck [2].
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Several alkaloids (papaverine, morphine, and cocaine) can cause different stimuli in the
nervous system of an animal; a common phenomenon in ecological relationships may
constitute, for example, a defense mechanism by plants against herbivores [1].
The importance of alkaloids in the development of medicine is unquestionable since several
advances made in the battle against diseases like malaria, leukemia, cancer, and neurodege‐
nerative diseases would not have occurred without the use of these substances [1].
This chapter focuses on the occurrence occurring, chemistry, and biological activity of the
quinoline and isoquinoline alkaloids, including the angustureine and congeneric alkaloids.
2. Quinoline and isoquinoline alkaloids
Among the various classes of alkaloid compounds, this section highlights the quinoline and
isoquinoline alkaloids. They were originally obtained from natural sources, whose remarkable
biological activities and relatively simple structures have attracted great interest in the
scientific community, especially researchers involved in the chemistry of natural products.
However, these compounds have also attracted the interest of synthetic organic chemists due
to the need to obtain increased amounts aimed at additional biological research, as well as in
developing efficient synthetic routes for these alkaloids and their derivatives, whose chemical
and biological properties could become greatly enhanced by the design of new structures from
these modifications.
2.1. Methods of extraction of quinoline and isoquinoline alkaloids
The general method for extracting and isolating alkaloids from plants consists of an acid-base
extraction. The dried and pulverized plant is extracted with organic solvents or with acidified
water. When the extraction is carried out with organic solvents immiscible with water, the
plant sample is alkalized prior to being extracted. For this, the sample is wrapped in filter
paper, as a cartridge, humidified with dilute basic solution, e.g., ammonium hydroxide, and
extracted under heating using Soxhlet apparatus with organic solvent such as ethyl ether,
chloroform, or dichloromethane. After extraction, the solvent volume is reduced by half in
rotary evaporator under reduced pressure. The remaining volume of the solvent containing
the alkaloid residue is transferred to a separatory funnel and extracted with aqueous phos‐
phoric acid solution (pH 1 to 2) or hydrochloric acid. The wetting of the plant sample with
basic solution allows the alkaloids are released from organic acids, thus facilitating its
extraction by organic solvents. Meanwhile, when using an acidified solution, alkaloids tend
to form salts with these strong acids, facilitating their removal from the two-phase system,
water-solvent for the separation of these into the aqueous phase [5].
Another extraction technique uses polar solvent such as ethanol, for example. However, if a
plant contains a high amount of lipids, a preextraction with a nonpolar solvent such as hexanes
or petroleum ether is necessary for removing these lipids. Next, the organic solvent is concen‐
trated under reduced pressure and the residue solubilized in water [6]. As most alkaloids are
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basic or are found in salt form, aqueous solutions of phosphoric acid (pH 1 to 2) or hydrochloric
acid are used for their removal. Neutral amide alkaloids, such as colchicine and piperine
(Figure 1), remain in the organic phase when treated with an organic solvent (usually ethyl
acetate) during the extraction process, while most of the other alkaloids may be extracted using
an organic solvent only after neutralization of the aqueous phase with a base [4].
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piperine
Figure 1. Structure of the neutral amide alkaloids colchicine and piperine.
Distillation methods are rarely employed for isolating alkaloids. This is possible only in cases
of low molecular weight alkaloids like coniine and sparteine (Figure 2) [4].
NH
coniine
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sparteine
H
Figure 2. Structure of the alkaloids coniine and sparteine.
Generally, the crude extract is purified by column chromatography (CC), employing silica gel
or alumina as the stationary phase and a mixture of appropriate solvents as the mobile phase,
following an appropriate choice made via thin layer chromatography (TLC). Often, alkaloids
still need additional purification by recrystallization, employing solvent systems such as
ethanol/water, methanol/chloroform, or acetone/methanol [4].
While these techniques are successful to extract and to isolate most alkaloids, for those highly
water soluble and, therefore, partially or totally insoluble in organic solvents, these methods
are not appropriates [6].
Although generally higher solubility in aqueous solutions involves greater bioactivities [6],
the employment of more suitable methods for the extraction of highly water-soluble alkaloids
is very useful.
In the case of quaternary alkaloids, the residual aqueous solution should be tested with a
reagent  suitable  for  the  detection  of  alkaloids  (Dragendorff  reagent,  for  example)  after
completion of conventional partition methods. If it  is positive, one should employ meth‐
ods  such  as  direct  crystallization,  precipitation  as  insoluble  salts,  extraction  with  polar
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solvent  water-immiscible,  or  formation of  pseudobases  to  extract  the  alkaloids  from the
aqueous phase [6].
Alkaloids N-oxides can be isolated by indirect methods or chemical derivatization, through a
reaction of reduction to the corresponding tertiary basis and extracted using the conventional
method, and subsequently regenerated by an oxidation reaction, using oxidizing agents such
as peroxide hydrogen or m-chloroperbenzoic acid. In some cases, the N-oxides containing
higher aliphatic chains can be almost completely extracted by increasing the basicity of the
aqueous phase, but for those who have high levels of hydroxylation, it is infeasible [6].
The methods employed to extract most common polyhydroxylated alkaloids are the direct
extraction and ion exchange chromatography [6].
After extraction of alkaloids, a quantitative analysis that may be performed by traditional
methods such as simple weighing or base titration after dilution under acidic conditions is
recommended. Other widely used techniques for the quantification of alkaloids are by
employing the HPLC apparatus with UV detection and by testing the refractive index
depending on the structure of the isolated compound(s) [5].
2.2. Occurrence in nature of quinoline and isoquinoline alkaloids
The quinoline and isoquinoline alkaloids were initially extracted from coal tar in 1834 and
1835, respectively. Quinoline, which has high boiling temperature, is commonly employed in
organic synthesis as a solvent. Isoquinoline has a low melting temperature and both have
moderate basicity (pKa = 4.9 and 5.1, respectively) [7].
Although the vast majority of quinoline and isoquinoline alkaloids derived from flowered
plants, they can also be isolated from animals and microorganisms, some representative
examples are given in Table 1 [7].
Structure Usual name Source Biological activity
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Structure Usual name Source Biological activity
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Structure Usual name Source Biological activity
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Structure Usual name Source Biological activity
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Structure Usual name Source Biological activity
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N
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N H
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CH3H3C Tubocurarin Chododendrontomentosum
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Table 1. Quinoline and isoquinoline alkaloids: natural sources and biological activities.
2.3. Biosynthetic origin of quinoline and isoquinoline alkaloids
The most One of the systems used for the classification of alkaloids is based on the kind of
nitrogen heterocycle in the structure and its botanical origin (plant family which is extracted);
thus, the name given to an alkaloid derived from the genus or species of organism produced,
including the term “ine.” Another commonly used system takes into account its precursor
amino acid. Thus, alkaloid derivatives of tryptophan and tyrosine are biosynthetically
classified as quinoline and isoquinoline, respectively (Figure 3) [3].
Thus, quinoline alkaloids are derived from 3-hydroxyanthranilic acid, a metabolite formed
from tryptophan through a sequence of enzymatic reactions (Figure 4). The condensation
between 3-hydroxyanthranilic acid and malonyl-SCoA, followed by cyclization, produces
quinoline alkaloid (Figure 4) [8-10].
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Figure 4. Biosynthesis of quinoline alkaloids.
In the case of isoquinoline systems, the biosynthesis proceeds from the cyclization of the Schiff
base formed between the dopamine and an aliphatic aldehyde [8]. Dopamine is obtained from
the hydroxylation and decarboxylation of tyrosine. A second intermediate, p-hydroxyphenyl
acetaldehyde, can also be formed by transamination, decarboxylation, and hydroxylation of
tyrosine. The condensation of these intermediates followed by a sequence of steps (cyclization,
hydroxylation, and methylation) produces the (S)-reticuline, a biosynthetic intermediate of all
isoquinoline alkaloids (Figure 5) [11].
2.4. Biological activities of quinoline and isoquinoline alkaloids
In addition to the biological activities shown in Table 1, many quinoline alkaloids and their
analogues represent the most important drugs currently used to combat malaria, with
chloroquine, amodiaquine, piperaquine, primaquine, quinine, and mefloquine (Figure 6)
NH
NH2
COOH
N
tryptophan quinoline
HO
COOH
NH2
tyrosine
N
isoquinoline
Figure 3. Structure of quinoline and isoquinoline alkaloids.
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being the most representative drugs of this group [12]. Even today, many studies are still being
conducted to increase the efficiency of quinoline derivatives such as AZT-chloro-quinoline,
quinine-dihydroartemisinin, and MEFAS, a salt derived from mefloquine and artesunate [13]
(Figure 7).
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NH3C
H3C
Cl
chloroquine
NCl
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CH3 CH3
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N
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CH3
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N
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HO NH
CF3
CF3
H
N
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Figure 6. Structure of some quinoline alkaloids and their analogues.
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Figure 5. Biosynthesis of isoquinoline alkaloids.
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Figure 7. Structure of other quinoline derivatives.
On the other hand, the quinoline nucleus has also demonstrated a critical role in the develop‐
ment of new anticancer drugs. Some of its derivatives showed excellent results on various
types of cancer cells, through different mechanisms of action. Recently, three protein kinase
inhibitors (Bosutinib, Lenvatinib, and Cabozantinib) and an inhibitor of farnesyltransferase
(Tipifarnib) (Figure 8), considered as potential anticancer agents, entered into phase of clinical
trials [14].
N
N NHH3CO
Cl Cl
OCH3
O N
N CH3
bosutinib
N
O
H3CO
H2N
O
Cl HN
O
HN
lenvatinib
N
O
H3CO
H3CO
HN
O
HN
O F
cabozantinib
NO
CH3
Cl
NH2
N
N
CH3
Cl
tipifarnib
Figure 8. Structure of bosutinib, lenvatinib, cabozantinib, and tipifarnib quinoline nucleus.
Knowing that functionalized quinolines have also shown high anti-carcinogenic potential, in
addition to acting as anti-angiogenic agents, and inhibitors of telomerase in various human
tumor cells, Muñoz and coworkers [15] selected the DM8 and DM12 tetrahydroquinolines
(Figure 9) for testing cytotoxic activity. They observed that individually these compounds
significantly inhibited cell growth of breast cancer, and when tested concomitantly with other
two anticancer drugs, they work synergistically to increase their cytotoxic activities. The results
obtained for the DM12 quinoline made this compound a promising candidate as a new
adjunctive anticancer agent.
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HN
NH2
CH3
OCH3
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NO2
CH3
OCH3
OH
DM12
O2N
Figure 9. Structure of the DM8 and DM12 tetrahydroquinoline alkaloids.
Furthermore, Villemagne and Okamura [16] obtained promising results with other quinoline
derivatives used as selective ligands for Tau proteins, associated with brain damage, which
represent a risk factor for diseases such as Alzheimer’s, which allowed the investigation of the
causes, diagnosis, and treatment of neurodegenerative diseases, encephalopathy, and trau‐
matic brain injury.
Biological activities of hundreds of other substituted quinolines have been reported, many of
which are promising in terms of their potential as pharmaceutical agents. 2-Methyl-5-hy‐
droxy-1,2,3,4-tetrahydroquinoline exhibits analgesic activity with a potency one-eighth that of
morphine [17]. 1,2,3,4-Tetrahydroquinoline-4-carboxylic acid is used in tissue-irrigating
solutions [18]. A wide array of other biological activities have been reported, including inter
alia inhibition of (H+/K+)-ATPase [19], blood serum monoamine oxidase [20], angiotensin I
converting enzyme [21], lipoxygenase [22], lipid peroxidation [23], bone resorption [24],
leukotriene synthesis [25, 26], and bacterial dihydrofolate reductase [27]. Relevance to many
other indications has also been noted [28-54].
In addition to the numerous utilities in the pharmacological area, studies are being performed
in order to investigate the potential activities of these alkaloids as agrochemical agents.
Sanguinarine and chelerythrine (Figure 10), for example, have shown high activity against
fungi and phytopathogenic bacteria in vitro, with sanguinarine being the most effective against
Rhizoctonia solani fungus, which has a wide range of hosts, which causes disease in most plants
grown in the world [55].
O
O
N
O
O
H3C
O
O
N
OCH3
OCH3
H3C
sanguinarine chelerythrine
Figure 10. Structure of the sanguinarine and chelerythrine agrochemical agents.
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3. Tetrahydroquinoline alkaloids angustureine, galipeine, galipinine, and
cuspareine
Among the simplest natural alkaloids that contain the 1,2,3,4-tetrahydroquinoline core are
angustureine and its congeners, galipeine, cuspareine, and galipinine (Figure 11). The struc‐
tures are more narrowly described as 2-alkyl-1-methyl-1,2,3,4-tetrahydroquinolines. They are
chiral by virtue of the stereogenic center at position 2. There is an excellent review of the
chemistry and synthesis of 1,2,3,4-tetrahydroquinolines by Diaz and Dudley [56].
N N
angustureine galipeine
OH
OCH3
N
cuspareine
OCH3
OCH3
N
galipinine
O
O
CH3 CH3
CH3 CH3
Figure 11. Structure of the 1,2,3,4-tetrahydroquinolin alkaloids angustureine, galipeine, cuspareine, and galipinine.
In 1999, Jacquemond-Collet and coworkers [57] isolated and characterized these four tetrahy‐
droquinoline alkaloids (Figure 11) from the extract of the bark of Galipea officinalis, commonly
known as “angostura” [58]. The genus Galipea comprises about 20 species that are found
predominantly in the Northern of South America. G. officinalis is a shrub known by rural
communities in the Venezuelan mountains for their pharmacological activities, and its extract
is used in the control of dyspepsia, dysentery, and chronic diarrhea, in addition to presenting
antimalarial, cytotoxic [59], molluscicidal activities, and antimicrobial properties, inhibiting
the growth of Mycobacterium tuberculosis, the etiological agent of tuberculosis [60].
In later trials, galipinine and galipeine exhibited promising biological activities in vitro such
as antimalarial (IC50: 0.24-6.12 and 0.33-13.78 mM, respectively) for the protozoa species
Plasmodium falciparum, one of the species causing malaria that is already resistant to chloro‐
quine, one of the main drugs used to combat the disease [61].
Due to their structural simplicities associated with the promising pharmacological activities,
these alkaloids, especially angustureine, have attracted the attention of the synthetic organic
community. For this alkaloid alone, more than 24 different syntheses have already been
described [62-85]. Some recent examples of the syntheses of these alkaloids are described
below.
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Diaz et al. [83] described the enantioselective synthesis of both alkaloids (R)-(-)- and (S)-(+)-
angustureine with overall yields of 80% and 44%, respectively, and excellent enantiomeric
excesses (95% and 96%, respectively), starting from the (S)-β-amino ester and (R)-sodium
carboxylate, prepared following enzymatic resolution of the β-amino ester racemate [86, 87].
Foubelo et al. [85] described a second-generation synthesis of (-)-angustureine by way of 2-
allyl-tetrahydroquinoline. A further sequence of three steps from this intermediate provided
angustureine in 36% overall yield. However, 2-allyl-tetrahydroquinolines can serve as
common precursors to various 2-substituted tetrahydroquinoline alkaloids by making use of
the cross-metathesis reaction with the Hoveyda-Grubbs reagent (second-generation rutheni‐
um catalyst) to achieve the appropriate side-chain homologation events.
In turn, Lam et al. [88] synthesized analogues of tetrahydroquinoline alkaloids employing
asymmetric hydrogenation catalyzed by iridium. These compounds were tested in vitro for
antitumor activities against lung cancer, breast cancer, hepatocellular carcinoma, and sarcoma
cancer and have achieved remarkable results, as well as in vivo, using mice as animal models
receiving hepatocellular tumor grafts, being that 1,2,3,4-tetrahydroquin-8-ol (Figure 12)
revealed the highest toxicity to human cancer cells.
NHOH
1,2,3,4-tetrahydroquin-8-ol
Figure 12. Structure of 1,2,3,4-tetrahydroquin-8-ol anticancer agent.
4. Concluding remarks
This chapter is an illustration of the fascinating world of chemistry of quinoline and isoqui‐
noline alkaloids. The range of pharmacological and agrochemical activities, among others,
associated with their biosynthetic routes and various natural sources demonstrates the creative
universe of the nature of these alkaloids. This universe of compounds arouses interest to
organic chemists in general, stimulated by the simplicity and its varied forms of exploitation
throughout constant search for the discovery of novel pharmacological agents targeting the
treatment of several diseases that affect society.
5. Future directions
In this chapter, we can verify the importance of quinoline and isoquinoline alkaloids due to
their potent biological activities demonstrated by in vitro and in vivo assays, as well as
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agrochemical agents reported throughout this chapter. Based on these facts, this family of
compounds is presented as an inexhaustible source for research groups working with natural
and synthetic products for the pharmaceutical area. In this context, our group intends to
continue the study of these alkaloids with the synthesis of novel quinoline and isoquinoline
derivatives, aimed at the discovery of new pharmacological agents.
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